|
Real-time Estimate
Tradegate
13:16:53 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 120.67 EUR | +1.78% |
|
-13.94% | +0.27% |
| 12:07pm | Palantir's AIPCon Highlights Data Sovereignty Demand, Ecosystem Adoption, Oppenheimer Says | MT |
| 09-11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.58% | +1.76% | -3.09% | +1.27% | +6.42% | +52.86% | +93.31% | +390.66% | +1,360.81% | 994B | |
| +0.75% | -0.60% | +2.75% | +13.51% | +29.26% | +50.79% | +63.37% | +62.32% | +126.96% | 640B | |
| +1.80% | +5.19% | +4.90% | +18.10% | +14.53% | +20.26% | +70.33% | +145.76% | +313.15% | 454B | |
| +5.00% | +2.21% | +1.77% | +10.82% | +10.12% | +38.79% | +39.24% | +4.39% | +51.34% | 337B | |
| +1.68% | -9.20% | -6.96% | -5.24% | +3.94% | +16.65% | +24.87% | +44.57% | +47.56% | 261B | |
| +3.81% | +0.93% | +6.06% | -7.92% | -11.86% | +6.48% | +12.39% | +49.50% | +145.44% | 246B | |
| +0.95% | -3.46% | -8.58% | +8.29% | +15.97% | +38.33% | +44.71% | +75.70% | +123.10% | 204B | |
| +1.43% | -6.21% | -4.85% | -1.82% | -13.79% | -21.04% | -58.94% | -11.18% | +83.69% | 190B | |
| +1.41% | -0.65% | +5.30% | +17.21% | +18.70% | +29.46% | +88.33% | +106.80% | +87.70% | 178B | |
| +0.13% | -0.14% | +3.58% | +6.73% | +11.45% | +15.77% | -18.74% | -37.93% | -18.24% | 158B | |
| +0.75% | -1.87% | +2.62% | +15.22% | +14.48% | +31.99% | +48.53% | +175.46% | +475.90% | 131B | |
| +0.93% | -0.83% | +0.50% | +14.06% | +18.93% | +38.40% | +7.83% | +3.28% | +16.15% | 130B | |
| +2.96% | -0.34% | -0.12% | -0.15% | -8.81% | -5.13% | -26.35% | -7.81% | +8.03% | 102B | |
| +4.74% | +0.93% | +2.04% | -5.29% | +1.64% | +25.39% | +24.70% | +4.91% | -8.05% | 95.94B | |
| -0.12% | -5.61% | -10.61% | -13.91% | -22.19% | -4.25% | +41.75% | +50.99% | +455.32% | 68.8B | |
| +1.25% | -0.28% | +3.20% | +12.89% | +18.66% | +27.69% | +21.65% | +53.52% | +21.73% | 58.91B | |
| +2.41% | +1.27% | +3.22% | +35.86% | +33.29% | +79.38% | +0.89% | +7.48% | -47.27% | 54.92B | |
| +2.04% | +2.01% | +1.56% | +7.10% | +18.84% | +86.10% | +259.05% | +299.25% | -28.04% | 43.22B | |
| +1.12% | -6.24% | -19.74% | -11.01% | -27.56% | -37.47% | +2.25% | -7.70% | +166.97% | 41.9B | |
| Average | +1.89% | -4.46% | -0.87% | +6.09% | +6.95% | +25.81% | +38.90% | +74.21% | +178.01% | 231B | |
| Weighted average by Cap. | +2.06% | -4.27% | -0.12% | +6.57% | +9.96% | +32.76% | +50.43% | +134.19% | +409.24% |
- Stock Market
- Stocks
- NOVN Stock
- NOT Stock
- Sector Novartis AG
Select your edition
All financial news and data tailored to specific country editions
